The analyses showed that COVID-19 patients with cardiovascular co-morbidities who also consumed statins had significantly lower plasma levels of IL-6 (adjusted p = 0.027), TNFα (adjusted p = 0.036), and IL-10 (adjusted p = 0.025) compared to COVID-19 patients with no CVD co-morbidities. This evidence concerns the gene TNF and COVID-19.